Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,250 | -2,520 | -2,500 | -1,880 | -770 |
| Depreciation Amortization | 100 | 70 | 70 | N/A | N/A |
| Other Working Capital | 120 | 550 | -650 | N/A | N/A |
| Other Operating Activity | 220 | 230 | 350 | 400 | 160 |
| Operating Cash Flow | $-1,810 | $-1,670 | $-2,730 | $-1,480 | $-610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -20 | -120 | N/A | N/A |
| Other Investing Activity | 0 | 40 | 240 | -780 | 0 |
| Investing Cash Flow | $-9 | $20 | $120 | $-780 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,750 | 1,500 | 2,940 | 2,250 | 640 |
| Financing Cash Flow | $1,750 | $1,500 | $2,940 | $2,250 | $640 |
| Beginning Cash Position | 210 | 360 | 20 | 40 | 8 |
| End Cash Position | 140 | 210 | 360 | 20 | 40 |
| Net Cash Flow | $-70 | $-140 | $340 | $-10 | $30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,810 | -1,670 | -2,730 | -1,480 | -610 |
| Free Cash Flow | -1,810 | -1,670 | -2,730 | -1,480 | -610 |